Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial-Reference-Cited by-同舟云学术

Diagnostic pathways in multiple myeloma and their relationship to end organ damage: an analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) trial

Published:2020-08-15 Issue:6 Volume:192 Page:997-1005
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Atkin Catherine¹^ORCID,Iqbal Gulnaz²,Planche Tim³,Pratt Guy⁴^ORCID,Yong Kwee⁵^ORCID,Wood Jill²,Raynes Kerry²,Low Eric⁶,Higgins Helen²,Neal Richard D.⁷,Dunn Janet²,Drayson Mark T⁸,Bowcock Stella⁹^ORCID, ,

Affiliation:

1. Institute of Inflammation and Ageing University of Birmingham Edgbaston BirminghamUK

2. Warwick Clinical Trials Unit University of Warwick CoventryUK

3. St George's University Hospitals NHS Trust LondonUK

4. University Hospitals Birmingham NHS Foundation Trust BirminghamUK

5. UCL Cancer InstituteUniversity College London LondonUK

6. Eric Low Consulting LondonUK

7. Institute of Health Sciences University of Leeds LeedsUK

8. Institute of Immunology and Immunotherapy University of Birmingham, Edgbaston BirminghamUK

9. Department of Haematological Medicine King’s College Hospital NHS Trust London UK

Funder

Health Technology Assessment Programme

Cancer Research UK

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjh.17044

Reference28 articles.

1. Cancer Research UK.Myeloma statistics: Cancer Research UK; [Cancer Research UK myeloma statistics.]. Available from:http://www.cancerresearchuk.org/health‐professional/cancer‐statistics/statistics‐by‐cancer‐type/myeloma

2. National Cancer Institute Surveillance Epidemiology And End Results Program.Cancer Stat Facts: Myeloma. Available from:https://seer.cancer.gov/statfacts/html/mulmy.html

3. Renal failure in multiple myeloma: reversibility and impact on the prognosis

4. Early Mortality After Diagnosis of Multiple Myeloma: Analysis of Patients Entered Onto the United Kingdom Medical Research Council Trials Between 1980 and 2002—Medical Research Council Adult Leukaemia Working Party

5. Fracture Risk With Multiple Myeloma: A Population-Based Study

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Laboratory practice is central to earlier myeloma diagnosis: Utilizing a primary care diagnostic tool and laboratory guidelines integrated into haematology services;British Journal of Haematology;2024-01-02

2. Patient-reported symptoms and diagnostic journey in Multiple Myeloma;Frontiers in Oncology;2023-11-30

3. Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity and Mortality in Myeloma (TEAMM) Trial;Cancers;2023-06-25

4. Development and Internal Validation of a Risk Prediction Model to Identify Myeloma Based on Routine Blood Tests: A Case-Control Study;Cancers;2023-02-03

5. Immunotherapy for Multiple Myeloma;Handbook of Cancer and Immunology;2023